Another important check point molecule, CTLA4 is broadly engaged in tumor immune evasion through the down-regulation of CD4+ T effector (Teff) cells and the enhancement of Treg cell activity (Topalian et al., 2016). This evidence concerns the gene CTLA4 and neoplasm.